Filter by: Subject

Filter by: Subject

Results Per Page:

Rheumatoid arthritis (RA) (11)
Chronic inflammation (2)
Patients (2)
South Africa (SA) (2)
Tobacco usage (2)
Airway microbiota (1)
Anti-CEP-1 (1)
Anti-citrullinated peptide (anti-CCP) (1)
Anti-citrullinated peptide antibodies (1)
Anti-citrullinated peptide antibodies (ACPAs) (1)
Anti-citrullinated peptide/protein antibodies (1)
Anti-cyclic citrullinated peptide antibodies (ACPA) (1)
Anti-MCV (1)
Anti-Sa (1)
Atmospheric pollution (1)
Autoantibodies (1)
Autoantibody (1)
Biomarkers (1)
C-reactive protein (1)
Cardiovascular disease (CVD) (1)
Cardiovascular risk (1)
Children (1)
Cotinine in serum (1)
Cyclic citrullinated peptide antibody (1)
Detection of synovitis (1)
Diagnosis (1)
Disease activity score (1)
Diseases (1)
Effects of drug treatment (1)
Efficacy (1)
Erosions (1)
Fluorescence analysis (1)
Functional disability (1)
Genetic predisposition (1)
Health-related quality of life (1)
Heavy metals (1)
Immune (1)
Immune dysregulation (1)
Immunogenicity (1)
Immunoglobulin A (1)
Immunoglobulin G antibody (1)
Inadequate response (1)
Inflammatory (1)
Inflammatory biomarkers (1)
Intestinal fatty acid-binding protein (1)
Intestinal fatty acid-binding protein (I-FABP) (1)
Intravenous abatacept (1)
Juvenile idiopathic arthritis (JIA) (1)
Laser nephelometry (1)
LPS-binding protein (LBP) (1)
Magnetic resonance imaging (MRI) (1)
MCV antibody (1)
Medical rehabilitation (1)
Methotrexate (1)
Microbial lipopolysaccharides (LPS) (1)
Peptidylarginine deiminases (1)
Predictive value (1)
Pulmonary surfactant protein D (SP-D) (1)
Rheumatoid arthritis patients (1)
Rheumatoid factor (1)
Rheumatoid factor (cRF) (1)
Safety (1)
Sensitivity (1)
Smoking cessation strategies (1)
Socio-economic status (1)
South Africa (1)
Specificity (1)
Subcutaneous abatacept (1)
Therapy (1)
Ultrasound imaging (USI) (1)